Catheter Precision, Inc.
VTAK
$0.4101
$0.02526.55%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 3.23% | 13.41% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.23% | 13.41% | |||
| Cost of Revenue | -37.50% | 220.00% | |||
| Gross Profit | 11.69% | 0.00% | |||
| SG&A Expenses | 6.23% | 2.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.16% | 4.15% | |||
| Operating Income | -5.23% | -3.86% | |||
| Income Before Tax | 2.37% | -57.76% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 2.37% | -57.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.37% | -57.76% | |||
| EBIT | -5.23% | -3.86% | |||
| EBITDA | -6.30% | -4.63% | |||
| EPS Basic | 63.95% | -54.75% | |||
| Normalized Basic EPS | 63.95% | -54.75% | |||
| EPS Diluted | 63.93% | -54.75% | |||
| Normalized Diluted EPS | 63.95% | -54.75% | |||
| Average Basic Shares Outstanding | 170.82% | 1.94% | |||
| Average Diluted Shares Outstanding | 170.82% | 1.94% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
